Part 8 Transitional provision in respect of homoeopathic medicinal productsF1
- 43List of countries for the purposes of the definition of “homoeopathic medicinal product” on IP completion day
- 44Place of establishment for holders of certificates of registration established in EEA before IP completion day
- 45Temporary exemption as to packaging requirements: change of place of establishment
- 46Applications made for a certificate of registration for a registrable homoeopathic product before IP completion day to which Chapter 4 of Title III of the 2001 Directive applied
- 47Suspensions of certificates of registration that have effect immediately before IP completion day that were imposed under Chapter 4 of Title III of the 2001 Directive
- 48Referrals made under Article 31 of the 2001 Directive concerning the suspension, variation or revocation of a certificate of registration that have not concluded before IP completion day
Annotations
Textual amendments
- F1
Sch. 33A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 7 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 193); 2020 c. 1, Sch. 5 para. 1(1)